UnannouncedVCRaise

Filed before 2025Filed 10 September 2024

Solarea Bio, Inc. raised $1M

Solarea Bio, Inc., a biotech company based in Waltham, MA, raised $1M in a new equity round, according to a filing dated 10 September 2024.

Raises filed before 2025 are not checked for a public announcement.

Filed
10 September 2024
Round
Equity round
Amount sold
$1M
Offering size
Open-ended
Investors so far
1
Based in
Waltham, MA
Website
solareabio.com

Investors on the board

Firms come from the venture funds whose filings name a director of this company.

Who is on the board

1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.

Sign in with Google

How it compares

Larger than 10% of the 1,434 tracked raises with an amount filed in 2024, and than 7% of the 138 in biotech.

Solarea Bio, Inc. in public filings

FiledFilingSoldRaise
20 Nov 2025New filing$9.91MAnother raise
10 Sep 2024New filing$1MThis raise
9 May 2023New filing$15MAnother raise
11 Sep 2020New filing$11.3MAnother raise

Everything on Solarea Bio, Inc.

More with BOLD Capital Associates on the board

  1. Gallant Pet, Inc.$10.2MAnnounced11 Jul 2025 · San Diego, CA
  2. Syntis Bio, Inc.$25MAnnounced2 Jul 2025 · Boston, MA
  3. Exo Imaging, Inc.$43.9MAnnounced11 Jun 2025 · Santa Clara, CA
  4. Viome Life Sciences, Inc.$25.4MFiled before 202528 Aug 2024 · Bellevue, WA

All 45 raises

Other unannounced rounds

  1. DVx Atomic Co.$18.5MUnannounced · 1 day16 Sep 2026 · Boston, MA
  2. Aperio Systems, Inc.$1.6MUnannounced · 1 day16 Sep 2026 · Boston, MA
  3. Twin Health, Inc.$59MUnannounced · 1 day16 Sep 2026 · Menlo Park, CA
  4. Scoring Factory AI Inc.$500KUnannounced · 2 days15 Sep 2026 · New York, NY
  5. Royal & Pelham, Inc.$5.4MUnannounced · 2 days15 Sep 2026 · New Orleans, LA
  6. SPECTRA Holdings US, Ltd.$2.5MUnannounced · 2 days15 Sep 2026 · Sandy Springs, GA

All unannounced rounds

Seen it announced?

Send the link and the check will look at it.